Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Fingolimod

EU orphan designation number: EU/3/09/718   
Active ingredient: Fingolimod
Indication: Treatment of chronic inflammatory demyelinating polyneuropathy
Sponsor: Novartis Europharm Limited
Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
04/02/2010 Centralised Orphan - Designation EMEA/OD/107/09 (2010)793 of 02/02/2010